Ausgabe 1/2024
Inhalt (20 Artikel)
Expanding the use of patient navigation: health coaching-based navigation as a novel approach to addressing deficits in breast cancer survivorship support
Bridget A. Oppong, Ruvarashe P. Rumano, Electra D. Paskett
Neoadjuvant endocrine treatment in hormone receptor-positive breast cancer: Does it result in more breast-conserving surgery?
Merel E. van de Loo, Layla Andour, Anne E. van Heesewijk, Hendrika M. Oosterkamp, Gerrit-Jan Liefers, Marieke E. Straver
The association of PD-L1 expression and CD8-positive T cell infiltration rate with the pathological complete response after neoadjuvant treatment in HER2-positive breast cancer
Kenan Çetin, Şermin Kökten, Bahar Sarıkamış, Sedat Yıldırım, Oruç Numan Gökçe, Nagehan Özdemir Barışık, Ülkan Kılıç
Poziotinib treatment in patients with HER2-positive advanced breast cancer who have received prior anti-HER2 regimens
Azadeh Nasrazadani, Juan Luis Gomez Marti, Kate Lathrop, Alvaro Restrepo, Szu-Yun Leu, Gajanan Bhat, Adam Brufsky
Real-world use of multigene signatures in early breast cancer: differences to clinical trials
Luca Licata, Rita De Sanctis, Andrea Vingiani, Deborah Cosentini, Monica Iorfida, Elena Rota Caremoli, Isabella Sassi, Bethania Fernandes, Andrea Gianatti, Elena Guerini-Rocco, Claudia Zambelli, Elisabetta Munzone, Edda Lucia Simoncini, Carlo Tondini, Oreste Davide Gentilini, Alberto Zambelli, Giancarlo Pruneri, Giampaolo Bianchini
Effect of metformin and lifestyle intervention on adipokines and hormones in breast cancer survivors: a pooled analysis from two randomized controlled trials
Harriet Johansson, Federica Bellerba, Debora Macis, Bjørn-Erik Bertelsen, Aliana Guerrieri-Gonzaga, Valentina Aristarco, Kristin Viste, Gunnar Mellgren, Giulia Di Cola, Jemos Costantino, Augustin Scalbert, Dorothy D. Sears, Sara Gandini, Andrea DeCensi, Bernardo Bonanni
Randomized placebo-controlled, double-blind clinical trial of nanoemulsion curcumin in women with aromatase inhibitor-induced arthropathy: an Alliance/NCORP pilot trial
Maryam Lustberg, Patty Fan-Havard, F. Lennie Wong, Kasey Hill, Mitch A. Phelps, Kevin W. Herrera, Ni-Chun Tsai, Timothy Synold, Ye Feng, Chidimma Kalu, Mina S. Sedrak, Lisa D. Yee
Effects of physical exercise during adjuvant chemotherapy for breast cancer on long-term tested and perceived cognition: results of a pragmatic follow-up study
Willeke R. Naaktgeboren, Emmie W. Koevoets, Martijn M. Stuiver, Wim H. van Harten, Neil K. Aaronson, Elsken van der Wall, Miranda Velthuis, Gabe Sonke, Sanne B. Schagen, Wim G. Groen, Anne M. May
Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a phase II trial
Noortje Verschoor, Manouk K. Bos, Ingeborg E. de Kruijff, Mai N. Van, Jaco Kraan, Jan C. Drooger, Johanna M. Zuetenhorst, Saskia M. Wilting, Stefan Sleijfer, Agnes Jager, John W. M. Martens
Deep learning-guided adjuvant chemotherapy selection for elderly patients with breast cancer
Enzhao Zhu, Linmei Zhang, Jiayi Wang, Chunyu Hu, Huiqing Pan, Weizhong Shi, Ziqin Xu, Pu Ai, Dan Shan, Zisheng Ai
Investigating the role of tumour-to-skin proximity in predicting nodal metastasis in breast cancer
Thiviya Sivakanthan, J. Tanner, B. Mahata, A. Agrawal
Comparison of long-term oncological outcomes after central lumpectomy versus nipple-sparing breast-conserving surgery for centrally located breast cancer: a propensity score-matched study
Yung-Huyn Hwang, Tae-Kyung Yoo, Sae Byul Lee, Jisun Kim, Il Yong Chung, Beom Seok Ko, Hee Jeong Kim, Jong Won Lee, Byung Ho Son
Omission of axillary lymph node dissection for breast cancer patients with three or more positive sentinel lymph nodes
Saranya Prathibha, McKenzie White, Madison Kolbow, Jane Yuet Ching Hui, David Brauer, Jacob Ankeny, Eric H. Jensen, Christopher J. LaRocca, Schelomo Marmor, Todd M. Tuttle
Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain
Susanne Fogh Jørgensen, Silje Sagstad, Javier Louro, Marta Román, Xavier Castells, Solveig Hofvind, Sisse Njor
Information needs in breast reconstruction after mastectomy: a qualitative analysis of free-text responses from 2077 women
Kim Wuyts, Vicki Durston, Lisa Morstyn, Sam Mills, Victoria White
MRI-visualized T2 hyperintense breast lesions: identifying clinical and imaging factors linked to malignant biopsy outcomes
Mary Beth Bissell, Sareh Keshavarsi, Rachel Fleming, Frederick Au, Supriya Kulkarni, Sandeep Ghai, Vivianne Freitas
Socio-cultural and financial issues against breast cancer screening behaviour among eligible Indian women: evidence for action
Shibaji Gupta, Sharmistha Sinha Gupta, Abhishek De, Rudradeep Banerjee, Sonu Goel
Exploration of MELK as a downstream of Del-1 and druggable targets in triple-negative breast cancer
In Hee Lee, Soo Jung Lee, Byeongju Kang, Jeeyeon Lee, Jin Hyang Jung, Ho Yong Park, Ji-Young Park, Nora Jee-Young Park, Eun Ae Kim, Jieun Kang, Yee Soo Chae
High tumor infiltrating lymphocytes are significantly associated with pathological complete response in triple negative breast cancer treated with neoadjuvant KEYNOTE-522 chemoimmunotherapy
Sarah J. Wood, Yuan Gao, Ji-Hoon Lee, Jessica Chen, Qun Wang, Jane L. Meisel, Xiaoxian Li
Real-world treatment patterns and clinical outcomes in patients treated with eribulin after prior phosphoinositide 3-Kinase inhibitor treatment for metastatic breast cancer
Ravi K. Goyal, Jingchuan Zhang, Keith L. Davis, Martina Sluga-O’Callaghan, Peter A. Kaufman